Brief: Galectin Says Will Require More Cash To Fund Operations After March 31, 2023

Galectin Therapeutics

31/03/2022 13:44

March 31 (Reuters) - Galectin Therapeutics Inc  GALT.O :
    * GALECTIN THERAPEUTICS INC - AS OF DECEMBER 31, 2021,
COMPANY HAD
$39.6 MILLION OF CASH AND CASH EQUIVALENTS
    * GALECTIN - BELIEVES HAS SUFFICIENT CASH TO FUND CURRENTLY
PLANNED OPERATIONS AND RESEARCH AND DEVELOPMENT ACTIVITIES
THROUGH AT LEAST MARCH 31, 2023
    * GALECTIN THERAPEUTICS INC - EXPECTS THAT IT WILL REQUIRE
MORE
CASH TO FUND OPERATIONS AFTER MARCH 31, 2023
    * GALECTIN THERAPEUTICS INC - BELIEVES IT WILL BE ABLE TO
OBTAIN
ADDITIONAL FINANCING AS NEEDED

Source text for Eikon:  ID:nGNX9YBqnd 
Further company coverage:  GALT.O 

 ((Reuters.Briefs@thomsonreuters.com;))